AC Immune (ACIU) News Today $2.08 +0.04 (+1.96%) Closing price 04:00 PM EasternExtended Trading$1.94 -0.14 (-6.73%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACIU Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Leerink Partnrs Raises Earnings Estimates for AC ImmuneJuly 14 at 2:11 AM | marketbeat.comAC Immune (NASDAQ:ACIU) Shares Down 3.9% - What's Next?July 7, 2025 | marketbeat.comACIU AC Immune SA - Seeking AlphaJune 29, 2025 | seekingalpha.comAC Immune SA (ACIU) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comAC Immune Ltd Analysis & Opinion (ACIU) - Investing.comJune 25, 2025 | investing.comNorthern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU)May 30, 2025 | marketbeat.comAC Immune SA Announces Board Changes Ahead of June 2025 AGMMay 19, 2025 | tipranks.comAC Immune (NASDAQ:ACIU) Upgraded to Buy at StockNews.comMay 15, 2025 | marketbeat.comAC Immune (ACIU) to Release Earnings on MondayMay 7, 2025 | marketbeat.comEquities Analysts Issue Forecasts for AC Immune Q2 EarningsMay 6, 2025 | marketbeat.comFY2027 EPS Estimates for AC Immune Reduced by HC WainwrightMay 4, 2025 | marketbeat.comAC Immune SA Reports Q1 2025 Financial Results and Clinical Advancements in Neurodegenerative Disease TherapiesMay 1, 2025 | nasdaq.comAC Immune SA: AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 1, 2025 | finanznachrichten.deAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateApril 30, 2025 | globenewswire.comIndividual investors in AC Immune SA (NASDAQ:ACIU) are its biggest bettors, and their bets paid off as stock gained 11% last weekApril 26, 2025 | finance.yahoo.comQ2 Earnings Forecast for AC Immune Issued By Leerink PartnrsApril 18, 2025 | marketbeat.comQ1 Earnings Forecast for AC Immune Issued By Leerink PartnrsApril 17, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Receives Buy Rating from HC WainwrightApril 5, 2025 | marketbeat.comAC Immune SA: Promising Phase 2 Results and Positive Outlook Drive Buy RatingApril 4, 2025 | tipranks.comAC Immune’s Strategic Advances and Financial HighlightsApril 2, 2025 | tipranks.comAC Immune announces additional data from Phase 2 study of VacSYn clinical trialApril 2, 2025 | markets.businessinsider.comAC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseApril 2, 2025 | markets.businessinsider.comAC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's DiseaseApril 2, 2025 | globenewswire.comShort Interest in AC Immune SA (NASDAQ:ACIU) Rises By 23.9%April 1, 2025 | marketbeat.comAC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025March 25, 2025 | globenewswire.comPromising Developments in AC Immune SA’s ACI-7104 Program Drive Buy RatingMarch 18, 2025 | tipranks.comAC Immune: Promising Pipeline and Financial Stability Drive Buy RatingMarch 17, 2025 | tipranks.comAC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years agoMarch 16, 2025 | finance.yahoo.comAC Immune (NASDAQ:ACIU) Receives "Buy" Rating from HC WainwrightMarch 15, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Releases Earnings Results, Beats Estimates By $0.03 EPSMarch 14, 2025 | marketbeat.comAC Immune reports FY24 EPS (51c), consensus (54c)March 13, 2025 | markets.businessinsider.comAC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateMarch 13, 2025 | globenewswire.comAC Immune (ACIU) Projected to Post Quarterly Earnings on ThursdayMarch 6, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Share Price Crosses Below 50-Day Moving Average - Should You Sell?March 5, 2025 | marketbeat.comAC Immune to Participate in Upcoming Investor ConferencesMarch 4, 2025 | markets.businessinsider.comAC Immune (NASDAQ:ACIU) Stock Price Passes Below 50 Day Moving Average - Should You Sell?February 23, 2025 | marketbeat.comAC Immune: Leader In Dementia Therapies, A Space Littered With FailuresFebruary 20, 2025 | seekingalpha.comAC Immune FY2024 EPS Forecast Increased by Leerink PartnrsJanuary 31, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Stock Passes Below Fifty Day Moving Average - Here's What HappenedJanuary 17, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Shares Down 4.4% - Here's What HappenedJanuary 8, 2025 | marketbeat.comAC Immune (NASDAQ:ACIU) Stock Passes Below 200-Day Moving Average - Here's What HappenedDecember 18, 2024 | marketbeat.comAC Immune Announces Promising Safety Data for Down Syndrome TherapyDecember 11, 2024 | markets.businessinsider.comAC Immune Reports Encouraging Interim Safety Data From ABATE Study Of ACI-24.060 In Down SyndromeDecember 10, 2024 | markets.businessinsider.comAC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndromeDecember 10, 2024 | markets.businessinsider.comAC Immune Q3 2024: Strong Progress and Financial TurnaroundNovember 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)November 19, 2024 | markets.businessinsider.comAC Immune SA: Promising Vaccine Developments and Strategic Partnerships Drive Buy RatingNovember 18, 2024 | markets.businessinsider.comPromising Interim Data and Safety Profile Justify Buy Rating for AC Immune’s ACI-7104.056 Vaccine TrialNovember 16, 2024 | markets.businessinsider.comAC Immune reports interim results from Phase 2 trial of ACI-7104.056November 15, 2024 | markets.businessinsider.comAC Immune’s Promising Trial Results for Parkinson’s TherapyNovember 15, 2024 | markets.businessinsider.com Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address ACIU Media Mentions By Week ACIU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACIU News Sentiment▼1.741.01▲Average Medical News Sentiment ACIU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACIU Articles This Week▼41▲ACIU Articles Average Week Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oculis News Today Chimerix News Today Avid Bioservices News Today uniQure News Today CorMedix News Today Cronos Group News Today GH Research News Today Syndax Pharmaceuticals News Today Immunome News Today Gyre Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACIU) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AC Immune Please log in to your account or sign up in order to add this asset to your watchlist. Share AC Immune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
